چکیده انگلیسی مقاله |
Background and Objectives : 300 Pseudomonas aeruginosa strains were isolated from hospitalized patients in Iran. Using international antigenic typing system (IATS) antibodies, all strains were classified into 16 serotypes while serotype 14 was not identified among the 17 known serotypes. To evaluate the rate of cross-reactivity between O- antigenic determinants, monospecific polyclonal antibodies were made against whole-killed-cells and live cells of each serotype. Material and Methods : Each antiserum was challenged against homologous and heterologous antigens using slide agglutination test. The degree of agglutination reaction is shown by -ve, 1+ve, 2+ve, 3+ve and 4ve for 0, 25%, 50%, 75% and 100% agglutination respectively. Then, the results were tabulated for further study. Results : The rate of cross-reactivity between O-antigenic determinants demonstrated that strains 10.55 and 15.14 had the highest agglutination reaction with serum of all the homologous and heterologous serotypes. Conclusion : Evaluation of the results obtained from the present study can be applied in production of reliable vaccines and antisera as therapeutic agents or as diagnostic kits. |
نویسندگان مقاله |
حسن احمدی | h ahmadi department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
s ملکیان | s malekian department of microbiology, islamic azad university, zanjan branch, iran.
سازمان اصلی تایید شده: دانشگاه آزاد اسلامی علوم و تحقیقات (Islamic azad university science and research branch)
b تبرایی | b tabaraie department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
d نوروزیان | d norouzian department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
f poormirza قلی | f poormirza gholi department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
m نجاتی | m nejati department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
mh هدایتی | mh hedayati department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
mr بیک محمدی | mr beik mohammadi department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
a behnoodi | a behnoodi department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
m ایزدپناهی | m izadpanahi department of bacterial vaccines and antigen production, pasteur institute of iran,tehran, iran.
سازمان اصلی تایید شده: انستیتو پاستور ایران (Pasteur institute of iran)
|